Sponsor:
Massachusetts General Hospital
Code:
NCT05205954
Conditions
Cirrhosis
End Stage Liver DIsease
Liver Cirrhosis
Liver Disease Chronic
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Hepatology Home Hospital
Brief summary:
Conditions
Cirrhosis
End Stage Liver DIsease
Liver Cirrhosis
Liver Disease Chronic
Study ID
NCT05205954
Start date
Jul 21, 2025
Status verified date
Jul, 2025
Completion date
Dec 31, 2026
Anticipated
Primary completion date
Dec 31, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
30 participants
Anticipated
Intervention Model
Single group
Primary purpose
Health Services Research
Arms
experimental: Hepatology Hospital at Home
Interventions
Hepatology Home Hospital
Primary outcome measure
Central contacts
William Munroe, BA
wlmunroe@mgh.harvard.eduLocations
Massachusetts General Hospital
Recruiting
Boston, Massachusetts, United States, 02114
Contacts
Principal Investigator:
Nneka Ufere, MD, MSCE
Massachusetts General Hospital
Recruiting
Boston, Massachusetts, United States, 02114
Sponsor
Massachusetts General Hospital
Last update posted
Jul 24, 2025
Last verified
Jul, 2025
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Massachusetts General Hospital on 2025-07-24.